Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies
出版年份 2023 全文链接
标题
Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies
作者
关键词
-
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 165, Issue -, Pages 115274
出版商
Elsevier BV
发表日期
2023-08-04
DOI
10.1016/j.biopha.2023.115274
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 55-OR: HSK7653, a Novel Ultralong-Acting DPP-4 Inhibitor, as Monotherapy in Patients With Type 2 Diabetes—A Randomized, Double-Blind, Placebo-Controlled Phase III Trial
- (2023) LINONG JI et al. DIABETES
- Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies
- (2023) Yujiao Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
- (2023) Julio Rosenstock et al. LANCET
- Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus
- (2022) Leilei Du et al. BIOMEDICINE & PHARMACOTHERAPY
- Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives
- (2022) Jasvinder Singh Bhatti et al. FREE RADICAL BIOLOGY AND MEDICINE
- Yogliptin monotherapy in type 2 diabetes: A 12‐week randomized, double‐blind, placebo‐controlled phase II study
- (2022) Xin Wang et al. Journal of Diabetes
- Potential of anthocyanin as an anti-inflammatory agent: a human clinical trial on type 2 diabetic, diabetic at-risk and healthy adults
- (2021) Elham Nikbakht et al. INFLAMMATION RESEARCH
- The therapeutic effects and mechanisms of salidroside on cardiovascular and metabolic diseases: An updated review
- (2021) Cheng-Cheng Zhao et al. CHEMISTRY & BIODIVERSITY
- Inflammatory markers response to crocin supplementation in patients with type 2 diabetes mellitus: A randomized controlled trial
- (2021) Vahideh Behrouz et al. PHYTOTHERAPY RESEARCH
- The effect of curcumin and zinc co‐supplementation on glycemic parameters in overweight or obese prediabetic subjects: A phase 2 randomized, placebo‐controlled trial with a multi‐arm, parallel‐group design
- (2021) Majid Karandish et al. PHYTOTHERAPY RESEARCH
- Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial
- (2021) Zahra Namkhah et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- The Therapeutic Effects and Mechanisms of Quercetin on Metabolic Diseases: Pharmacological Data and Clinical Evidence
- (2021) Huan Yi et al. Oxidative Medicine and Cellular Longevity
- Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial
- (2021) Fatemeh Naeini et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
- (2021) David C W Lau et al. LANCET
- Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2020) Maryam Saberi-Karimian et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results
- (2020) K.J. Lucas et al. DIGESTIVE AND LIVER DISEASE
- Magnoflorine: A review of its pharmacology, pharmacokinetics and toxicity
- (2020) Tong Xu et al. PHARMACOLOGICAL RESEARCH
- The effect of resveratrol supplementation on serum levels of asymmetric de‐methyl‐arginine and paraoxonase 1 activity in patients with type 2 diabetes: A randomized, double‐blind controlled trial
- (2020) Mahtab Tabatabaie et al. PHYTOTHERAPY RESEARCH
- Genistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects
- (2020) Martha Guevara-Cruz et al. BMJ Open Diabetes Research & Care
- A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial
- (2020) Mitra Hariri et al. COMPLEMENTARY THERAPIES IN MEDICINE
- The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial
- (2020) Zahra Yari et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
- (2020) Stephen A. Harrison et al. GASTROENTEROLOGY
- Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD
- (2020) Antonella Mosca et al. DIGESTIVE AND LIVER DISEASE
- Randomized double‐blind clinical trial examining the Ellagic acid effects on glycemic status, insulin resistance, antioxidant, and inflammatory factors in patients with type 2 diabetes
- (2020) Mahnaz Ghadimi et al. PHYTOTHERAPY RESEARCH
- Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence
- (2020) Xinmei Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Seed peptide lunasin ameliorates obesity-induced inflammation and regulates immune responses in C57BL/6J mice fed high-fat diet
- (2020) Chia-Chien Hsieh et al. FOOD AND CHEMICAL TOXICOLOGY
- The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial
- (2019) Mahsa Adibian et al. PHYTOTHERAPY RESEARCH
- Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
- (2019) Seyed Ali Jazayeri-Tehrani et al. Nutrition & Metabolism
- Obesity: global epidemiology and pathogenesis
- (2019) Matthias Blüher Nature Reviews Endocrinology
- Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial
- (2019) Eunok Lee et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
- (2019) Arrigo F. G. Cicero et al. EUROPEAN JOURNAL OF NUTRITION
- Effectiveness of genistein supplementation on metabolic factors and antioxidant status in postmenopausal women with type-2 diabetes mellitus
- (2019) Hassan Braxas et al. Canadian Journal of Diabetes
- Circulating Oxidative Stress Biomarkers in Clinical Studies on Type 2 Diabetes and Its Complications
- (2019) Elisabetta Bigagli et al. Oxidative Medicine and Cellular Longevity
- The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial
- (2019) Homa Hodaei et al. Diabetology & Metabolic Syndrome
- Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial
- (2019) Yunes Panahi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effects of curcumin supplementation on markers of inflammation and oxidative stress among healthy overweight and obese girl adolescents: A randomized placebo‐controlled clinical trial
- (2019) Sahar Saraf‐Bank et al. PHYTOTHERAPY RESEARCH
- Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus
- (2019) Masafumi Funamoto et al. Journal of Diabetes Research
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
- (2018) ShadiSadat Seyyedebrahimi et al. ACTA DIABETOLOGICA
- Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial
- (2018) Sasan Amanat et al. CLINICAL NUTRITION
- Acute administration of capsaicin increases resting energy expenditure in young obese subjects without affecting energy intake, appetite, and circulating levels of orexigenic/anorexigenic peptides
- (2018) Antonello E. Rigamonti et al. NUTRITION RESEARCH
- Resveratrol supplementation decreases blood glucose without changing the circulating CD14 + CD16 + monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
- (2018) Hadi Khodabandehloo et al. NUTRITION RESEARCH
- Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders
- (2018) Marialetizia Rastelli et al. Obesity
- Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial
- (2018) Fatemeh Homayouni et al. PHYTOTHERAPY RESEARCH
- The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome
- (2018) Masoud Khorshidi et al. PHYTOTHERAPY RESEARCH
- Efficacy of phospholipidated curcumin in nonalcoholic fatty liver disease: a clinical study
- (2018) Yunes Panahi et al. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
- Obesity, diabetes, and the gut microbiome: an updated review
- (2018) Tahli Singer-Englar et al. Expert Review of Gastroenterology & Hepatology
- Type 2 diabetes
- (2017) Sudesna Chatterjee et al. LANCET
- Hesperidin Supplementation Alleviates Oxidative DNA Damage and Lipid Peroxidation in Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Clinical Trial
- (2017) Fatemeh Homayouni et al. PHYTOTHERAPY RESEARCH
- Metabolism disrupting chemicals and metabolic disorders
- (2017) Jerrold J. Heindel et al. REPRODUCTIVE TOXICOLOGY
- Anthocyanin supplementation in alleviating thrombogenesis in overweight and obese population: A randomized, double-blind, placebo-controlled study
- (2017) Kiara Thompson et al. Journal of Functional Foods
- Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes—A Randomized Controlled Trial
- (2017) Liping Yang et al. Nutrients
- Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level1,2
- (2016) Silvia Sookoian et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial
- (2016) I-Ju Chen et al. CLINICAL NUTRITION
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders
- (2016) Birgit Waltenberger et al. MOLECULES
- Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
- (2016) Sepideh Rahmani et al. PHYTOTHERAPY RESEARCH
- The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis
- (2016) Ahmad Zare Javid et al. PHYTOTHERAPY RESEARCH
- Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial
- (2016) Yunes Panahi et al. INFLAMMOPHARMACOLOGY
- Impact of sub-gastrectomy on glucose regulation in gastric cancer patients with T2DM: a follow-up study
- (2015) You Cheng Zhang et al. International Journal of Diabetes in Developing Countries
- Purified Anthocyanin Supplementation Reduces Dyslipidemia, Enhances Antioxidant Capacity, and Prevents Insulin Resistance in Diabetic Patients
- (2015) Dan Li et al. JOURNAL OF NUTRITION
- Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
- (2015) Hong-Mei Yan et al. PLoS One
- Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus
- (2015) Xiao-Wei Zhu et al. Primary Care Diabetes
- Evaluation of the Effect of Curcumin Capsules on Glyburide Therapy in Patients with Type-2 Diabetes Mellitus
- (2014) Prasad Neerati et al. PHYTOTHERAPY RESEARCH
- Investigation of the Effects of Curcumin on Serum Cytokines in Obese Individuals: A Randomized Controlled Trial
- (2014) Shiva Ganjali et al. TheScientificWorldJOURNAL
- Diabetes in China: a societal solution for a personal challenge
- (2014) Juliana C N Chan et al. Lancet Diabetes & Endocrinology
- Effects of curcumin on brain-derived neurotrophic factor levels and oxidative damage in obesity and diabetes
- (2013) Elena Franco-Robles et al. Applied Physiology Nutrition and Metabolism
- The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men
- (2013) E Konings et al. INTERNATIONAL JOURNAL OF OBESITY
- Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial
- (2013) Somlak Chuengsamarn et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
- (2013) Melania Gaggini et al. Nutrients
- Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
- (2012) X. Wang et al. DIABETES CARE
- Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial
- (2012) Li-Xin Na et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
- (2012) Jayesh Kumar Bhatt et al. NUTRITION RESEARCH
- Lipid-lowering effect of berberine in human subjects and rats
- (2012) Yueshan Hu et al. PHYTOMEDICINE
- Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
- (2011) Pál Brasnyó et al. BRITISH JOURNAL OF NUTRITION
- Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
- (2011) Silvie Timmers et al. Cell Metabolism
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants
- (2011) Mariel M Finucane et al. LANCET
- The Role of Cytokines in Non-Alcoholic Fatty Liver Disease
- (2010) Herbert Tilg DIGESTIVE DISEASES
- Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study
- (2009) Sarah Egert et al. BRITISH JOURNAL OF NUTRITION
- Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial
- (2009) Manal F. Abdelmalek et al. HEPATOLOGY
- Circulating oxidized LDL levels, current smoking and obesity in postmenopausal women
- (2008) E. Kassi et al. ATHEROSCLEROSIS
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
- (2008) Yifei Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of berberine in patients with type 2 diabetes mellitus
- (2008) Jun Yin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus
- (2008) P Usharani et al. Drugs in research & development
- Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet
- (2007) Maiana Verdelho Machado et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now